Press Room

British Dragon Pharma is a pioneer and world leader in the development, manufacturer and marketing of controlled-release pharmaceutical products. British Dragon's shares are listed on the New York (NYSE) and Toronto Stock Exchange (TSX).

The British Dragon Press Room features the latest press releases and scientific and financial news on the company and its products, as well as a select archive of press releases and related materials.

How to Use Crypto Payments ?
How to Use Crypto Payments ?

Wondering how to use Crypto payment methods on British Dragon store ? Here is a guide on how to proceed easily with crypto payments.

Gynecomastia  - A Common Side Effect Of Steroid Use
Apr 3, 2024 British Dragon
Gynecomastia - A Common Side Effect Of Steroid Use

Gynecomastia is generally the medical term used to refer to a development of breast tissues in male steroid users. This commonly occurs when a male steroid user is presented with the unusually very high level of estrogen in the body, out of steroid use.

Post Cycle Therapy (PCT)
Post Cycle Therapy (PCT)

Post cycle therapy is a method of employing drugs which work via various mechanisms to go about trying to aid stabilizing and restoring a user's hormones back to normal once a suppressive anabolic androgenic steroid cycle has been ceased.

Patent For Innovative Nanoparticle
Patent For Innovative Nanoparticle

British Dragon Pharma announced today that it has received a U.S. patent relating to its calcium phosphate nanoparticles (CAP). In addition to disclosing the compound itself, the new patent discloses methods of manufacture and use of CAP.

Transmucosal Insulin Administration
Transmucosal Insulin Administration

British Dragon Pharma announced today that it presented pre-clinical data suggesting its transmucosal insulin can deliver significant dosages of insulin into the bloodstream

Significant Testabol Propionate Phase II Efficacy Results
Significant Testabol Propionate Phase II Efficacy Results

British Dragon Pharma announced new Testabol Propionate (bioidentical testosterone propionate) Phase II clinical trial efficacy data will be presented today at the annual meeting of the American Society for Reproductive Medicine (ASRM) in Philadelphia.

Customer Reviews

Please leave your feedback on products or service below.
Thank you beforehand.

Write a Review View Reviews

Add in Cart - Product(s)

Close Button
Empty

Total Cost: